Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The revision tag on the page updates from v3.5.3 to v3.5.4. This represents a minor site maintenance update and does not imply changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-15T02:13:01.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a small update to the page’s revision history. The update does not affect the main study details or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T17:22:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Updated site revision from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:59:56.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Padua, Italy was replaced by Padova, Italy in the locations list. This updates the site entry to the native Italian name for accuracy.
    Difference
    0.1%
    Check dated 2026-04-09T08:32:12.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added revision label v3.5.0 and removed revision label v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:04:57.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:46:16.000Z thumbnail image

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.